Home
Archives
Jerusalem Center Homepage
View the current issue
Jerusalem Center Videos
Additional Resources
Top Commentators:
- Elliott Abrams
- Fouad Ajami
- Shlomo Avineri
- Benny Avni
- Alan Dershowitz
- Jackson Diehl
- Dore Gold
- Daniel Gordis
- Tom Gross
- Jonathan Halevy
- David Ignatius
- Pinchas Inbari
- Jeff Jacoby
- Efraim Karsh
- Mordechai Kedar
- Charles Krauthammer
- Emily Landau
- David Makovsky
- Aaron David Miller
- Benny Morris
- Jacques Neriah
- Marty Peretz
- Melanie Phillips
- Daniel Pipes
- Harold Rhode
- Gary Rosenblatt
- Jennifer Rubin
- David Schenkar
- Shimon Shapira
- Jonathan Spyer
- Gerald Steinberg
- Bret Stephens
- Amir Taheri
- Josh Teitelbaum
- Khaled Abu Toameh
- Jonathan Tobin
- Michael Totten
- Michael Young
- Mort Zuckerman
Think Tanks:
- American Enterprise Institute
- Brookings Institution
- Center for Security Policy
- Council on Foreign Relations
- Heritage Foundation
- Hudson Institute
- Institute for Contemporary Affairs
- Institute for Counter-Terrorism
- Institute for Global Jewish Affairs
- Institute for National Security Studies
- Institute for Science and Intl. Security
- Intelligence and Terrorism Information Center
- Investigative Project
- Jerusalem Center for Public Affairs
- RAND Corporation
- Saban Center for Middle East Policy
- Shalem Center
- Washington Institute for Near East Policy
Media:
- CAMERA
- Daily Alert
- Jewish Political Studies Review
- MEMRI
- NGO Monitor
- Palestinian Media Watch
- The Israel Project
- YouTube
Government:
Back
(Jerusalem Post) Tzvi Joffre - Five patients recently discharged from Hadassah Medical Center were healthy and coronavirus-free after taking part in the first clinical trial of an innovative treatment. All five had been hospitalized in serious or critical condition. The drug Allocetra is based on research conducted by Prof. Dror Mevorach, director of the internal medicine and coronavirus departments at Hadassah. Mevorach explained, "Its activity is carried out by treating cells taken from a healthy donor and engineering them in the laboratory in a way that, when they are injected into the patient's body, will control the inflammation or storm of cytokines that is very harmful to patients."2020-10-01 00:00:00Full Article
Clinical Trial at Hadassah Hospital: 5 Serious Corona Patients Now Healthy
(Jerusalem Post) Tzvi Joffre - Five patients recently discharged from Hadassah Medical Center were healthy and coronavirus-free after taking part in the first clinical trial of an innovative treatment. All five had been hospitalized in serious or critical condition. The drug Allocetra is based on research conducted by Prof. Dror Mevorach, director of the internal medicine and coronavirus departments at Hadassah. Mevorach explained, "Its activity is carried out by treating cells taken from a healthy donor and engineering them in the laboratory in a way that, when they are injected into the patient's body, will control the inflammation or storm of cytokines that is very harmful to patients."2020-10-01 00:00:00Full Article
Search Daily Alert
|
Search:
|